These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11438836)

  • 1. Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine.
    Parker SE; Monteith D; Horton H; Hof R; Hernandez P; Vilalta A; Hartikka J; Hobart P; Bentley CE; Chang A; Hedstrom R; Rogers WO; Kumar S; Hoffman SL; Norman JA
    Gene Ther; 2001 Jul; 8(13):1011-23. PubMed ID: 11438836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
    Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z
    Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits.
    Parker SE; Borellini F; Wenk ML; Hobart P; Hoffman SL; Hedstrom R; Le T; Norman JA
    Hum Gene Ther; 1999 Mar; 10(5):741-58. PubMed ID: 10210142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
    Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
    Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.
    Wang R; Richie TL; Baraceros MF; Rahardjo N; Gay T; Banania JG; Charoenvit Y; Epstein JE; Luke T; Freilich DA; Norman J; Hoffman SL
    Infect Immun; 2005 May; 73(5):2863-72. PubMed ID: 15845492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.
    Sedegah M; Charoenvit Y; Aguiar J; Sacci J; Hedstrom R; Kumar S; Belmonte A; Lanar DE; Jones TR; Abot E; Druilhe P; Corradin G; Epstein JE; Richie TL; Carucci DJ; Hoffman SL
    Genes Immun; 2004 Nov; 5(7):553-61. PubMed ID: 15318164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antivirus effect of plasmid co expressing hepatitis B surface antigen and granulocyte macrophage-colony stimulating factor].
    Qing YL; Zhao JJ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):201-4. PubMed ID: 15099465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection.
    Ismael AB; Hedhli D; Cérède O; Lebrun M; Dimier-Poisson I; Mévélec MN
    Vaccine; 2009 May; 27(22):2959-66. PubMed ID: 19428907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF).
    Lima J; Jenkins C; Guerrero A; Triozzi PL; Shaw DR; Strong TV
    Vaccine; 2005 Jan; 23(10):1273-83. PubMed ID: 15652670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and general safety of a naked DNA plasmid, GTU-MultiHIV, in a rat, using a quantitative PCR method.
    Tuomela M; Malm M; Wallen M; Stanescu I; Krohn K; Peterson P
    Vaccine; 2005 Jan; 23(7):890-6. PubMed ID: 15603889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag.
    Qiu JT; Chang TC; Lin CT; Chen YM; Li FQ; Soong YK; Lai CH
    Vaccine; 2007 Jan; 25(2):253-63. PubMed ID: 16971027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plasmid DNA encoding the porcine granulocyte-macrophage colony-stimulating factor on antigen-presenting cells in pigs.
    Melkebeek V; Van den Broeck W; Verdonck F; Goddeeris BM; Cox E
    Vet Immunol Immunopathol; 2008 Oct; 125(3-4):354-60. PubMed ID: 18762341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
    Yo YT; Hsu KF; Shieh GS; Lo CW; Chang CC; Wu CL; Shiau AL
    Cancer Gene Ther; 2007 Nov; 14(11):904-17. PubMed ID: 17704754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models.
    Quezada A; Larson J; French M; Ponce R; Perrard J; Durland R; Coleman M
    J Pharm Pharmacol; 2004 Feb; 56(2):177-85. PubMed ID: 15005876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modulation of immune response to Plasmodium falciparum apical membrane antigen 1 DNA vaccine by cytokine plasmids].
    Li X; Miao J; Lei JC; Xue CF; Wang XF; Liu ZX; Li SM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):136-8. PubMed ID: 15597706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific immune responses in Balb/c mice induced by plasmid coexpressing hepatitis B surface antigen and granulocyte-macrophage colony stimulating factor].
    Qing YL; Ling N; Zhao JJ; Peng ML; Xu HM; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):474-6. PubMed ID: 12939179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine.
    Hartoonian C; Ebtekar M; Soleimanjahi H; Karami A; Mahdavi M; Rastgoo N; Azadmanesh K
    Cytokine; 2009 Apr; 46(1):43-50. PubMed ID: 19278866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
    Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
    Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
    Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.